“In the past year we have worked closely with Morpheus Biolabs to acquire in vivo and in vitro data in support of one of our drug discovery programs.  The Morpheus team has provided us with extensive consulting support and high quality pharmacology services at competitive prices. Alex Okyay’s highly collaborative approaches to problem solving and technical expertise have significantly accelerated our preclinical research.”

Robert L. Davis, Ph.DLudwig Institute for Cancer Research– San Diego Branch

“The Morpheus BioLab team has provided excellent services on flow cytometry-based experiments. They help in every step of the way- from planning of the experiments to data analysis. Very knowledgeable and willing to take extra time to review the data with our team… a great help to many of our programs.”

Samantha Murphy, Ph.DArcturus Therapeutics - a leading company on messenger RNA (mRNA) therapeutics

“We have worked with Morpheus BioLabs for two years on our pre-clinical viral and cell biology assets in immuno-oncology. Morpheus has consistently delivered well-run experiments, and we would be delighted to return to Morpheus for more work. With Morpheus’s help, we were able to get our in vitro studies done to support our IP strategy as well as to show to investors the mechanisms of action for our assays.

We would be more than happy to recommend Morpheus BioLabs’ team. They have been instrumental in rapidly deploying assays that helped us demonstrate what we needed.”

PrimeVax Immuno-OncologyA pioneering company in developing dengue fever to treat late stage cancer.